JPS62195558A - 血球の標識化方法 - Google Patents
血球の標識化方法Info
- Publication number
- JPS62195558A JPS62195558A JP798387A JP798387A JPS62195558A JP S62195558 A JPS62195558 A JP S62195558A JP 798387 A JP798387 A JP 798387A JP 798387 A JP798387 A JP 798387A JP S62195558 A JPS62195558 A JP S62195558A
- Authority
- JP
- Japan
- Prior art keywords
- blood cells
- cycloalkyl
- blood
- aralkyl
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000601 blood cell Anatomy 0.000 title claims description 33
- 238000002372 labelling Methods 0.000 title claims description 18
- 238000000034 method Methods 0.000 title claims description 12
- 210000000265 leukocyte Anatomy 0.000 claims description 13
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 10
- 125000004432 carbon atom Chemical group C* 0.000 claims description 9
- 210000003743 erythrocyte Anatomy 0.000 claims description 9
- -1 propylene amine oxime Chemical class 0.000 claims description 9
- GKLVYJBZJHMRIY-OUBTZVSYSA-N Technetium-99 Chemical compound [99Tc] GKLVYJBZJHMRIY-OUBTZVSYSA-N 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 8
- 125000003118 aryl group Chemical group 0.000 claims description 8
- 239000000725 suspension Substances 0.000 claims description 6
- 230000007935 neutral effect Effects 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 239000006285 cell suspension Substances 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- JKVVXCJYWCLUMO-UHFFFAOYSA-N 3-[[2,2-dimethyl-3-(3-oxobutan-2-ylamino)propyl]amino]butan-2-one Chemical group CC(=O)C(C)NCC(C)(C)CNC(C)C(C)=O JKVVXCJYWCLUMO-UHFFFAOYSA-N 0.000 claims 1
- 229940056501 technetium 99m Drugs 0.000 claims 1
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 7
- 210000002381 plasma Anatomy 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 6
- 229940125782 compound 2 Drugs 0.000 description 6
- 210000003714 granulocyte Anatomy 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 210000004556 brain Anatomy 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 238000010828 elution Methods 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 229910052713 technetium Inorganic materials 0.000 description 3
- GKLVYJBZJHMRIY-UHFFFAOYSA-N technetium atom Chemical compound [Tc] GKLVYJBZJHMRIY-UHFFFAOYSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 208000027866 inflammatory disease Diseases 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 2
- FWPIDFUJEMBDLS-UHFFFAOYSA-L tin(II) chloride dihydrate Chemical compound O.O.Cl[Sn]Cl FWPIDFUJEMBDLS-UHFFFAOYSA-L 0.000 description 2
- IJRKANNOPXMZSG-SSPAHAAFSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC(=O)CC(O)(C(O)=O)CC(O)=O IJRKANNOPXMZSG-SSPAHAAFSA-N 0.000 description 1
- 239000005725 8-Hydroxyquinoline Substances 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000028018 Lymphocytic leukaemia Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 229940055742 indium-111 Drugs 0.000 description 1
- APFVFJFRJDLVQX-AHCXROLUSA-N indium-111 Chemical compound [111In] APFVFJFRJDLVQX-AHCXROLUSA-N 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 208000003747 lymphoid leukemia Diseases 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 229960003540 oxyquinoline Drugs 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1203—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules in a form not provided for by groups A61K51/1206 - A61K51/1296, e.g. cells, cell fragments, viruses, virus capsides, ghosts, red blood cells, viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Dispersion Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8601003 | 1986-01-16 | ||
| GB868601003A GB8601003D0 (en) | 1986-01-16 | 1986-01-16 | Labelling blood cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62195558A true JPS62195558A (ja) | 1987-08-28 |
| JPH0445107B2 JPH0445107B2 (enExample) | 1992-07-23 |
Family
ID=10591472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP798387A Granted JPS62195558A (ja) | 1986-01-16 | 1987-01-16 | 血球の標識化方法 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0229718B1 (enExample) |
| JP (1) | JPS62195558A (enExample) |
| DE (1) | DE3769321D1 (enExample) |
| GB (1) | GB8601003D0 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5026913A (en) * | 1989-12-12 | 1991-06-25 | Medi-Physics, Inc. | Hydrocarbylphenyl diaminodithiol derivatives |
| US5080884A (en) * | 1989-12-12 | 1992-01-14 | Medi-Physics, Inc. | Hydrocarbylphenyl diaminodithiol radionuclide complexes and their use in imaging |
| US5143713A (en) * | 1990-05-30 | 1992-09-01 | Board Of Regents, The University Of Texas System | 99m Tc labeled liposomes |
| GB2279607A (en) * | 1993-06-21 | 1995-01-11 | Shell Int Research | Manufacture of elastic articles from poly monovinylaromatic conjugated diene block copolymers |
| US6653299B1 (en) | 1997-01-21 | 2003-11-25 | Nycomed Amersham Plc | Labelled factor XIIIa substrates |
| US7049140B1 (en) | 1999-04-29 | 2006-05-23 | Vanderbilt University | X-ray guided drug delivery |
| US6159443A (en) * | 1999-04-29 | 2000-12-12 | Vanderbilt University | X-ray guided drug delivery |
| US7906102B2 (en) | 2001-10-03 | 2011-03-15 | Vanderbilt University | Ligands to radiation-induced molecules |
| US7306925B2 (en) | 2001-11-09 | 2007-12-11 | Vanderbilt University | Phage antibodies to radiation-inducible neoantigens |
| CU23844B1 (es) | 2009-04-17 | 2012-10-15 | Ct De Neurociencias De Cuba | Procedimiento de obtención de nuevos derivados de naftaleno para el diagnóstico in vivo de la enfermedad de alzheimer |
| US10449261B2 (en) | 2014-07-24 | 2019-10-22 | Washington University | Compositions targeting radiation-induced molecules and methods of use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4615876A (en) * | 1983-04-25 | 1986-10-07 | Curators Of The University Of Missouri | Macrocyclic complexes of technetium-99m for use as diagnostic radionuclides |
| GB8426845D0 (en) * | 1984-10-24 | 1984-11-28 | Amersham Int Plc | Complexes of technetium-99m |
| DE3687467T2 (de) * | 1985-03-11 | 1993-04-29 | Amersham Int Plc | Komplexe von technetium-99m mit propylen-amin-oximen. |
-
1986
- 1986-01-16 GB GB868601003A patent/GB8601003D0/en active Pending
-
1987
- 1987-01-14 EP EP19870300302 patent/EP0229718B1/en not_active Expired
- 1987-01-14 DE DE8787300302T patent/DE3769321D1/de not_active Expired - Lifetime
- 1987-01-16 JP JP798387A patent/JPS62195558A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| GB8601003D0 (en) | 1986-02-19 |
| EP0229718B1 (en) | 1991-04-17 |
| EP0229718A3 (en) | 1988-02-24 |
| DE3769321D1 (de) | 1991-05-23 |
| JPH0445107B2 (enExample) | 1992-07-23 |
| EP0229718A2 (en) | 1987-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0038756B1 (en) | Cationic lipophilic complexes of 99m tc useful for myocardial and hepatobiliary imaging | |
| US5679318A (en) | Stable therapeutic radionuclide compositions and methods for preparation thereof | |
| US5393512A (en) | Stable therapeutic radionuclide compositions and methods for preparation thereof | |
| EP0107734A1 (en) | ISONITRILE RADIONUCLEID COMPLEXES FOR LABELING AND IMAGING AGENTS. | |
| IL107560A (en) | Kit for making radiopharmaceutical preparations containing the Technium-M99 complex | |
| CA1111765A (en) | Reductant composition for technetium-99m and method for making technetium-99m labelled ligands | |
| EP0183555B1 (en) | Metal-isonitrile adducts for preparing radionuclide complexes for labelling and imaging agents | |
| CA1215372A (en) | Radioactive chelate complexes containing pyridine-n-oxides | |
| JPH0445107B2 (enExample) | ||
| Dewanjee et al. | Indium-111 tropolone, a new tracer for platelet labeling. | |
| Rousseau et al. | Synthesis, tissue distribution and tumor uptake of [99Tc] tetrasulfophthalocyanine | |
| JPH06502640A (ja) | テクネチウム−９９ｍ錯化合物の放射性医薬としての使用 | |
| CA1324317C (en) | Stable radiodiagnostic products, and the preparation thereof | |
| Chiotellis et al. | 99mTc-labelled N-substituted carbamoyl iminodiacetates: relationship between structure and biodistribution | |
| Kempi et al. | 99mTc-DTPA (Sn) Dry-Kit Preparation Quality Control and Clearance Studies | |
| EP0179481B1 (en) | Stable stannous chloride composition for labeling with radioactive technetium | |
| US4448762A (en) | Complex of transferrin with ruthenium for medical applications | |
| US4118468A (en) | Technetium-99m-labelled diagnostic agent for kidney scanning and process for its manufacture | |
| CA1067403A (en) | Technetium-99m labeled radiodiagnostic agents for liver and bone marrow scanning and method of preparation | |
| Joist et al. | Methodologic and basic aspects of indium-111 platelets | |
| US4705678A (en) | Sterile radioactive indium-containing aqueous solution | |
| Srivastava et al. | Tumor uptake of radioruthenium compounds | |
| WO1991004057A1 (en) | Stable therapeutic radionuclide compositions and methods for preparation thereof | |
| ATE65917T1 (de) | Herstellung eines tc-99m radiopharmaka. | |
| Srivastava et al. | Recent developments in blood cell labeling research |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: R3D02 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: R3D04 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |